CCR5 and cancer: To date, HIV cure was achieved in only two people who received bone marrow transplantation to treat cancer using donor cells carrying the delta 32 mutation in the ccr5 gene (CCR5δ32/δ32) (135), a mutation known to confer resistance to CCR5-tropic HIV infection (86).